2m 2m 2m 2m 2m 2m 2m
Insmed (INSM)
NASDAQ
$118.85-$1.90 (-1.57%)
Price as of Nov 12, 2026 9:12 AM EST- $26.5BMarket Cap
- -37.88%1-Year Change
- BiotechnologyIndustry
Insmed (INSM)
$118.85-$1.90 (-1.57%)
INSM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $120.75 | ||
Change | +$1.26 (+1.05%) | ||
Open | $119.49 | ||
High | $120.88 | ||
Low | $117.26 | ||
Previous Close | $119.49 | ||
Volume | 1,488,924 | ||
30-Day Average Volume | 3,493,606 | ||
1-Week Change | 9.77% | ||
1-Month Change | 20.03% | ||
1-Year Change | -37.88% | ||
3-Year Change | 408.42% | ||
5-Year Change | 279.60% | ||
Fundamentals | |||
Shares Outstanding | 219.4M | ||
Total Assets | $2.2B | ||
Market Cap | $26.5B | ||
Enterprise Value | $26.6B | ||
Period: QTR TTM FY | |||
Revenue | $524.4M | ||
Net Income | -$100.3M | ||
Free Cash Flow | -$42.1M | ||
EBIT | -$97.7M | ||
EBITDA | -$92.6M | ||
Net Working Capital | $1.1B | ||
EPS | -$0.46 | ||
Enterprise Value/EBITDA | -288 | ||
Enterprise Value/Revenue | 51 | ||
P/B | 36 | ||
P/E | -263 | ||
PEG | 0 | ||
Price/Free Cash Flow | -629 | ||
Price/Operating Cash Flow | -727 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 03/03/2011 | ||
Earnings & Revenue